Indeed, PD-associated LRRK2 mutations cause increased kinase activity and are associated with decreased mitophagy while genetic or pharmacological inhibition of LRRK2 kinase activity restores mitophagy (Bonello et al., 2019; Korecka et al., 2019; Wauters et al., 2020). Here, LRRK2 is linked to Parkinson disease.